Get Live Data

REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS: SocGen Downgrades Rolls-Royce To Sell

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,809.50
Bid: 1,809.50
Ask: 1,810.00
Change: -0.50 (-0.03%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,811.00
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: SocGen Downgrades Rolls-Royce To Sell

Mon, 16th Jun 2014 09:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BARCLAYS RAISES RSA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 538 (102) PENCE
----------
SOCGEN CUTS ROLLS-ROYCE TO 'SELL' ('HOLD') - TARGET 950 (1070) PENCE
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 2100 (2075) PENCE - 'BUY'
----------
HSBC RAISES BG GROUP PRICE TARGET TO 1425 (1260) PENCE - 'OVERWEIGHT'
----------
EXANE RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4500) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS BHP BILLITON PRICE TARGET TO 1850 (2000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS RIO TINTO PRICE TARGET TO 3800 (4070) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES WEIR GROUP PRICE TARGET TO 2540 (2390) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
GOLDMAN RAISES HISCOX PRICE TARGET TO 607 (606,74) PENCE - 'SELL'
----------
HSBC RAISES PARAGON GROUP PRICE TARGET TO 380 (335) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES DEBENHAMS TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - TP 73 (64) PENCE
----------
CREDIT SUISSE CUTS FENNER PRICE TARGET TO 405 (490) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES HALMA PRICE TARGET TO 665 (620) PENCE - 'OUTPERFORM'
----------
CREDIT SUISSE RAISES LAIRD PRICE TARGET TO 270 (215) PENCE - 'UNDERPERFORM'
----------
CREDIT SUISSE RAISES MORGAN ADVANCED MATERIALS TP TO 310 (270) PENCE - 'UNDERPEFORM'
----------
CREDIT SUISSE RAISES ROTORK PRICE TARGET TO 2600 (2450) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES SENIOR PLC PRICE TARGET TO 335 (315) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
NUMIS CUTS CRODA PRICE TARGET TO 2554 (2575) PENCE - 'HOLD'
----------
CANACCORD CUTS IG GROUP PRICE TARGET TO 659 (711) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SHANKS GROUP PRICE TARGET TO 119 (122) PENCE - 'NEUTRAL'
----------
LIBERUM INITIATES NCC GROUP WITH 'BUY' - TARGET 220 PENCE
----------
Investec Cuts Majestic Wine To Add from Buy, PT 460p
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
34567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.